• Can changes in EEG improve neuropathic pain treatments - read Oct newsletter.
  • Nine posters ready to reveal at the SfN virtual conference 8-11 Nov, booth 1818.
  • Joined-up preclinical and clinical trials to advance psilocybin drug development
  • Transpharmation joins HaPpY team to help break the vicious cycle of chronic pain & mood disorders, see News for details
  • Announcing new premises in Poland with a focus on neuropsychiatric disorders...
  • New state-of-the-art premises at Discovery Park, Kent


All the latest conference updates; those that we are attending and the studies that we are presenting

The ICRS is dedicated to scientific research in all fields of the cannabinoids, ranging from biochemical, chemical, and physiological studies.

Transpharmation has a poster 'Investigating NLRP3-inhibitory potential of CBD' on display at this symposium during the daily poster sessions. It will be made available to you in the publications page of this website after the event. In the meantime, please feel free to read the abstract here: View Abstract.

For the full poster presentation see our publication.


Start a Conversation

preclinical +44 (0)203 633 2807

clinical trials +353 (0)1896 42 60

clinical research +48 515 244 120

EEG contact@transpharmation.co.uk

Copyright ©2021 Transpharmation Ltd. Website created by Identity Ipswich Web Design